financetom
Business
financetom
/
Business
/
Persistent Systems Q1 net profit up 8 percent but misses estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Persistent Systems Q1 net profit up 8 percent but misses estimates
Jul 20, 2023 8:33 AM

Mid-tier IT company Persistent Systems on Thursday, July 20, reported an 8 percent year-on-year (YoY) jump in net profit at Rs 228.8 crore for the first quarter that ended June 30, 2023.

In the corresponding quarter last year, the company posted a net profit of Rs 212 crore, the company said in a regulatory filing. CNBC-TV18 Polls had predicted a profit of Rs 278 crore for the quarter under review.

In the quarter, total revenue stood at Rs 2,321.2 crore, up 23 percent against Rs 2,321 crore in the corresponding period of the preceding fiscal. CNBC-TV18 Polls had predicted revenue of Rs 2,325 crore for the quarter under review.

On a sequential basis, Persistent Systems' net profit declined 9.1 percent from Rs 251.5 crore reported in the March quarter of FY23.

The order booking for the quarter ended on June 30, 2023, was at $380.3 million in total contract value (TCV) and at $271.9 million in annual contract value (ACV) terms.

Chief Executive Officer and Executive Director of Persistent Sandeep Kalra said the company commenced the year by celebrating a significant milestone of surpassing $1 billion in annual revenue. “As the company enters a new fiscal year, I’m pleased to share that we have sustained our growth momentum despite the challenging macroeconomic conditions,” he said.

"We also want to extend our warm welcome to Dr Ajit Ranade, a renowned academician, corporate executive, economist and thought leader, as an independent director to our board. He will bring his impressive experience of 32+ years to help guide our strategy and accelerate our growth journey," Kalra said.

The results came after the close of the market hours. Shares of Persistent Systems Ltd ended at Rs 5,050.80, down by Rs 88.35, or 1.72 percent on the BSE.

(Edited by : Shoma Bhattacharjee)

First Published:Jul 20, 2023 5:33 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2025 - www.financetom.com All Rights Reserved